We are live on ! Find out more
Nuveen

Nuveen Portfolio holdings

AUM $419B
1-Year Est. Return 43.02%
This Fund
S&P 500
This Quarter Est. Return
+1.8%
1 Year Est. Return
+43.02%
3 Year Est. Return
+139.43%
5 Year Est. Return
+185.66%
10 Year Est. Return
+615.13%
AUM
$247B
AUM Growth
-$6.76B
Cap. Flow
-$7.91B
Cap. Flow %
-3.2%
Top 10 Hldgs %
17.52%
Holding
3,301
New
48
Increased
1,481
Reduced
1,530
Closed
86

Sector Composition

Rank Sector Weight
1 Technology 19.96%
2 Financials 14.59%
3 Healthcare 12.49%
4 Consumer Discretionary 10.56%
5 Communication Services 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACRS icon
3151
Aclaris Therapeutics
ACRS
$758M
$125K ﹤0.01%
115,438
-12,522
-10% -$17.8K
GDP
3152
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$125K ﹤0.01%
11,730
– –
SER icon
3153
Serina Therapeutics
SER
$53.1M
$124K ﹤0.01%
1,805
+313
+21% +$29.7K
BCEL
3154
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$124K ﹤0.01%
+10,109
New +$154K
LFC
3155
DELISTED
China Life Insurance Company Ltd.
LFC
$120K ﹤0.01%
10,380
-473
-4% -$5.77K
DTIL icon
3156
Precision BioSciences
DTIL
$172M
$114K ﹤0.01%
453
– –
BXG
3157
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
$114K ﹤0.01%
12,203
-23,433
-66% -$238K
USWS
3158
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$110K ﹤0.01%
2,382
– –
FINV
3159
FinVolution Group
FINV
$734M
$108K ﹤0.01%
37,100
+2,300
+7% +$8.81K
TPST icon
3160
Tempest Therapeutics
TPST
$13.7M
$106K ﹤0.01%
76
– –
BEDU
3161
DELISTED
Bright Scholar Education Holdings
BEDU
$105K ﹤0.01%
+2,725
New +$103K
NTGN
3162
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$105K ﹤0.01%
61,206
+37,098
+154% +$113K
INSE icon
3163
Inspired Entertainment
INSE
$120M
$104K ﹤0.01%
14,395
– –
NAAS
3164
NaaS Technology Inc
NAAS
$55.6M
$104K ﹤0.01%
2
+1
+100% +$67.7K
VBIV
3165
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$104K ﹤0.01%
7,346
– –
NTP
3166
DELISTED
Nam Tai Property Inc.
NTP
$104K ﹤0.01%
11,505
+1,026
+10% +$9.81K
CHGA
3167
Change Agents Corp
CHGA
$2.35M
$102K ﹤0.01%
18
– –
QTT
3168
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$102K ﹤0.01%
2,760
+250
+10% +$10.6K
SUPV
3169
Grupo Supervielle
SUPV
$634M
$101K ﹤0.01%
31,600
-100,000
-76% -$522K
ROAN
3170
DELISTED
Roan Resources, Inc.
ROAN
$100K ﹤0.01%
81,431
-7,880
-9% -$10.3K
JILL icon
3171
J. Jill
JILL
$366M
$99K ﹤0.01%
10,414
– –
SIEB icon
3172
Siebert Financial
SIEB
$90.4M
$94K ﹤0.01%
10,249
– –
ECOR icon
3173
electroCore
ECOR
$100M
$88K ﹤0.01%
2,682
+1,855
+224% +$58.6K
SFUN
3174
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$88K ﹤0.01%
3,928
+1,964
+100% +$43.3K
CRESY
3175
Cresud
CRESY
$901M
$85K ﹤0.01%
15,280
-3,847
-20% -$29.2K

Similar funds

Nuveen's Q3 2019 Portfolio in Review

As of Q3 2019, Nuveen held 3,301 positions worth $247B, down 2.7% from $254B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nuveen withdrew a net $7.91B in Q3 2019, closing 86 positions and reducing 1,530 holdings. Its most notable exit was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $1.13B position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Nuveen opened a new position in Medallia, Inc. worth $97.7M.

  • Nuveen's largest Q3 2019 buy was Medallia, Inc.: 3,562,327 shares worth $97.7M.
  • Nuveen added most to Fidelity National Information Services in Q3 2019, an estimated $508M increase.
  • Nuveen's biggest Q3 2019 reduction was Microsoft, cutting an estimated $408M.
  • Nuveen fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2019, selling an estimated $1.13B.
  • Nuveen's ten largest holdings make up 18% of its $247B portfolio in Q3 2019.
  • Nuveen opened 48 new positions and closed 86 in Q3 2019.
  • Nuveen's portfolio value fell 2.7% quarter-over-quarter to $247B.

Based on Nuveen's 13F filing for Q3 2019, filed 14 Nov 2019.